PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea
· Delayed Price · Currency is KRW 401,500
-9,500 (-2.31%)
At close: Dec 5, 2025
PharmaResearch Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 167,393 | 165,348 | 67,245 | 72,931 | 41,674 | 26,715 | Upgrade
|
| Short-Term Investments | 294,547 | 230,480 | 56,549 | 67,989 | 2,000 | 8,981 | Upgrade
|
| Trading Asset Securities | 77,265 | 41,523 | 36,505 | 43,423 | 113,123 | 43,571 | Upgrade
|
| Cash & Short-Term Investments | 539,205 | 437,351 | 160,298 | 184,343 | 156,798 | 79,267 | Upgrade
|
| Cash Growth | 149.16% | 172.84% | -13.04% | 17.57% | 97.81% | 14.83% | Upgrade
|
| Accounts Receivable | 50,481 | 38,460 | 31,400 | 32,304 | 27,741 | 22,827 | Upgrade
|
| Other Receivables | 8,633 | 4,052 | 3,301 | 2,757 | 975.32 | 873.4 | Upgrade
|
| Receivables | 70,528 | 56,564 | 35,998 | 36,234 | 30,490 | 26,343 | Upgrade
|
| Inventory | 71,055 | 57,325 | 50,232 | 24,453 | 17,342 | 20,781 | Upgrade
|
| Prepaid Expenses | 3,798 | 950.54 | 1,191 | 667.94 | 701.54 | 373.73 | Upgrade
|
| Other Current Assets | 7,060 | 2,351 | 8,746 | 1,647 | 1,460 | 639.42 | Upgrade
|
| Total Current Assets | 691,644 | 554,542 | 256,465 | 247,345 | 206,792 | 127,404 | Upgrade
|
| Property, Plant & Equipment | 166,572 | 147,313 | 123,061 | 117,960 | 109,481 | 94,046 | Upgrade
|
| Long-Term Investments | 69,784 | 85,811 | 99,107 | 40,718 | 44,911 | 42,511 | Upgrade
|
| Goodwill | 13,856 | 13,856 | 11,652 | 13,810 | 16,764 | 12,492 | Upgrade
|
| Other Intangible Assets | 18,916 | 18,309 | 18,821 | 22,720 | 24,825 | 26,233 | Upgrade
|
| Long-Term Deferred Tax Assets | 3,613 | 8,557 | 4,476 | 8,667 | 3,166 | 3,162 | Upgrade
|
| Long-Term Deferred Charges | 1,001 | 1,227 | 1,502 | 1,297 | 1,200 | 578.13 | Upgrade
|
| Other Long-Term Assets | 20,930 | 23,745 | 16,259 | 21,105 | 15,715 | 13,407 | Upgrade
|
| Total Assets | 988,303 | 855,701 | 535,281 | 478,055 | 427,647 | 319,831 | Upgrade
|
| Accounts Payable | 12,014 | 11,081 | 2,831 | 3,527 | 2,939 | 1,876 | Upgrade
|
| Accrued Expenses | - | 1,493 | 974.34 | 860.08 | 702.95 | 533.87 | Upgrade
|
| Short-Term Debt | 7,696 | 9,359 | 32,345 | 18,867 | 18,873 | 17,854 | Upgrade
|
| Current Portion of Long-Term Debt | 34.13 | 20 | 33.3 | 87.4 | 726.52 | 610 | Upgrade
|
| Current Portion of Leases | 2,137 | 2,421 | 628.25 | 1,620 | 1,161 | 1,117 | Upgrade
|
| Current Income Taxes Payable | 18,328 | 23,355 | 11,357 | 10,136 | 6,851 | 6,222 | Upgrade
|
| Current Unearned Revenue | 4.7 | 7.89 | 27.69 | 11.36 | - | - | Upgrade
|
| Other Current Liabilities | 51,152 | 34,400 | 17,703 | 19,144 | 16,751 | 7,637 | Upgrade
|
| Total Current Liabilities | 91,366 | 82,137 | 65,899 | 54,253 | 48,005 | 35,849 | Upgrade
|
| Long-Term Debt | 200,930 | 195,865 | 970.72 | 45,359 | 43,385 | 10,505 | Upgrade
|
| Long-Term Leases | 528.88 | 1,121 | 329.91 | 835.48 | 1,466 | 2,324 | Upgrade
|
| Pension & Post-Retirement Benefits | 2,162 | 1,816 | 1,181 | 562.74 | 743.68 | 862.55 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1,644 | 2,156 | 2,794 | 3,741 | 4,514 | 4,746 | Upgrade
|
| Other Long-Term Liabilities | 2,222 | 2,485 | 1,911 | 1,648 | 1,175 | 1,133 | Upgrade
|
| Total Liabilities | 298,853 | 285,580 | 73,087 | 106,399 | 99,288 | 55,420 | Upgrade
|
| Common Stock | 5,255 | 5,255 | 5,160 | 5,056 | 5,056 | 4,895 | Upgrade
|
| Additional Paid-In Capital | 198,076 | 197,312 | 175,428 | 157,582 | 152,413 | 133,405 | Upgrade
|
| Retained Earnings | 459,541 | 343,061 | 260,787 | 190,862 | 154,018 | 112,615 | Upgrade
|
| Treasury Stock | - | -4,638 | -4,638 | -5,260 | -5,260 | -5,260 | Upgrade
|
| Comprehensive Income & Other | -1,886 | -1,588 | -3,633 | -4,737 | -785.15 | -232.35 | Upgrade
|
| Total Common Equity | 660,987 | 539,402 | 433,104 | 343,503 | 305,442 | 245,423 | Upgrade
|
| Minority Interest | 27,789 | 30,038 | 29,091 | 28,153 | 22,917 | 18,989 | Upgrade
|
| Shareholders' Equity | 689,451 | 570,121 | 462,195 | 371,656 | 328,359 | 264,411 | Upgrade
|
| Total Liabilities & Equity | 988,303 | 855,701 | 535,281 | 478,055 | 427,647 | 319,831 | Upgrade
|
| Total Debt | 211,326 | 208,786 | 34,307 | 66,768 | 65,611 | 32,410 | Upgrade
|
| Net Cash (Debt) | 327,879 | 228,565 | 125,991 | 117,575 | 91,187 | 46,857 | Upgrade
|
| Net Cash Growth | 77.70% | 81.41% | 7.16% | 28.94% | 94.61% | -2.56% | Upgrade
|
| Net Cash Per Share | 31568.51 | 22202.30 | 11932.17 | 11785.88 | 9070.92 | 4928.76 | Upgrade
|
| Filing Date Shares Outstanding | 10.39 | 10.39 | 10.2 | 9.98 | 9.98 | 9.65 | Upgrade
|
| Total Common Shares Outstanding | 10.39 | 10.39 | 10.2 | 9.98 | 9.98 | 9.65 | Upgrade
|
| Working Capital | 600,278 | 472,405 | 190,566 | 193,092 | 158,787 | 91,555 | Upgrade
|
| Book Value Per Share | 63619.74 | 51917.28 | 42459.18 | 34433.24 | 30617.96 | 25424.37 | Upgrade
|
| Tangible Book Value | 628,214 | 507,238 | 402,631 | 306,974 | 263,854 | 206,698 | Upgrade
|
| Tangible Book Value Per Share | 60465.43 | 48821.45 | 39471.79 | 30771.48 | 26449.11 | 21412.71 | Upgrade
|
| Land | 22,450 | 21,051 | 18,617 | 18,617 | 14,064 | 14,064 | Upgrade
|
| Buildings | 81,818 | 79,470 | 81,472 | 80,151 | 52,235 | 52,135 | Upgrade
|
| Machinery | 58,874 | 52,305 | 41,375 | 30,766 | 27,162 | 22,544 | Upgrade
|
| Construction In Progress | 47,631 | 31,510 | 12,459 | 12,200 | 32,985 | 16,386 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.